Home
>
National Drug Code (NDC)
>
Zantac 75
Zantac 75 - 0597-0122-08 - (ranitidine)
Drug Information of Zantac 75
| Product NDC: | 0597-0122 |
| Proprietary Name: | Zantac 75 |
| Non Proprietary Name: | ranitidine |
| Active Ingredient(s): | 75 mg/1 & nbsp; ranitidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zantac 75
| Product NDC: | 0597-0122 |
| Labeler Name: | Boehringer Ingelheim Pharmaceuticals Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA020520 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20061221 |
Package Information of Zantac 75
| Package NDC: | 0597-0122-08 |
| Package Description: | 1 TABLET, COATED in 1 POUCH (0597-0122-08) |
NDC Information of Zantac 75
| NDC Code | 0597-0122-08 |
| Proprietary Name | Zantac 75 |
| Package Description | 1 TABLET, COATED in 1 POUCH (0597-0122-08) |
| Product NDC | 0597-0122 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | ranitidine |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20061221 |
| Marketing Category Name | NDA |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals Inc. |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
